104 Publications (Page 1 of 5)
2021
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.
Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅⋅Van der Jeught, Kevin⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Yu, Tao⋅Yu, Tao⋅Yu, Tao⋅Yu, Tao⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Ao, Zheng⋅Ao, Zheng⋅Ao, Zheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Yang, Yang⋅Yang, Yang⋅Yang, Yang⋅Yang, Yang⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Haniyeh, Eyvani⋅Cox, Mary L⋅Cox, Mary L⋅Cox, Mary L⋅Cox, Mary L⋅Wang, Xiyu⋅Wang, Xiyu⋅Wang, Xiyu⋅Wang, Xiyu⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Guo, Feng⋅Guo, Feng⋅Guo, Feng⋅Guo, Feng⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Zhang, Xinna⋅Zhang, Xinna⋅⋅Zhang, Xinna⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin and
Nature biomedical engineering, vol. 5, (no. 11), pp. 1320-1335, November 2021. | Journal Article
 
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
Niu, Yi⋅Lin, Ziyou⋅Wan, Arabella⋅Sun, Lei⋅Yan, Shijia⋅Liang, Heng⋅Zhan, Siyue⋅Chen, Dongshi⋅Bu, Xianzhang⋅Liu, Peiqing⋅Chen, Ceshi⋅He, Weiling⋅Lu, Xiongbin and Wan, Guohui
Hepatology (Baltimore, Md.), vol. 74, (no. 3), pp. 1461-1479, September 2021. | Journal Article
 
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation
Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Y, Fang⋅Fang, Yuanzhang⋅Wang, Lifei⋅L, Wang⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅C, Wan⋅Wan, Changlin⋅Wan, Changlin⋅Wan, Changlin⋅Wan, Changlin⋅Sun, Yifan⋅Sun, Yifan⋅Y, Sun⋅Sun, Yifan⋅Sun, Yifan⋅Jeught K, Van⋅VAn der Jeught, Kevin⋅VAn der Jeught, Kevin⋅VAn der Jeught, Kevin⋅VAn der Jeught, Kevin⋅Zhou, Zhuolong⋅Z, Zhou⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Dong, Tianhan⋅T, Dong⋅Dong, Tianhan⋅Dong, Tianhan⋅Dong, Tianhan⋅So, Ka M⋅KM, So⋅So, Ka M⋅So, Ka M⋅So, Ka M⋅Yu, Tao⋅Yu, Tao⋅T, Yu⋅Yu, Tao⋅Yu, Tao⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Y, Li⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅H, Eyvani⋅Eyvani, Haniyeh⋅Colter, Austyn B⋅Colter, Austyn B⋅Colter, Austyn B⋅Colter, Austyn B⋅AB, Colter⋅Dong, Edward⋅E, Dong⋅Dong, Edward⋅Dong, Edward⋅Dong, Edward⋅Cao, Sha⋅Cao, Sha⋅Cao, Sha⋅Cao, Sha⋅S, Cao⋅J, Wang⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅BP, Schneider⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Sandusky, George E⋅Sandusky, George E⋅X, Zhang⋅Sandusky, George E⋅Sandusky, George E⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna and Zhang, Xinna
Journal of Clinical Investigation, vol. 131, (no. 1), pp. 1-17, Jan 2021. | Journal Article
 
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer
Sun, Lei⋅Wan, Arabella⋅Zhou, Zhuolong⋅Chen, Dongshi⋅Liang, Heng⋅Liu, Chuwei⋅Yan, Shijia⋅Niu, Yi⋅Lin, Ziyou⋅Zhan, Siyue⋅Wang, Shanfeng⋅Bu, Xianzhang⋅He, Weiling⋅Lu, Xiongbin⋅Xu, Anlong and Wan, Guohui
Gut, vol. 70, (no. 9), pp. 1698-1712, Sep 2021. | Journal Article
 
Targeted immunotherapy for HER2-low breast cancer with 17p loss.
Li, Yujing⋅Sun, Yifan⋅Kulke, Michael⋅Hechler, Torsten⋅Van der Jeught, Kevin⋅Dong, Tianhan⋅He, Bin⋅Miller, Kathy D⋅Radovich, Milan⋅Schneider, Bryan P⋅Pahl, Andreas⋅Zhang, Xinna and Lu, Xiongbin
Science translational medicine, vol. 13, (no. 580), February 10, 2021. | Journal Article
2020
Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
Xu, Jiangsheng⋅Xu, Jiangsheng⋅Liu, Yunhua⋅Liu, Yunhua⋅Li, Yujing⋅Li, Yujing⋅Wang, Hai⋅Wang, Hai⋅Stewart, Samantha⋅Stewart, Samantha⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Liu, Sheng⋅Liu, Sheng⋅Zhao, Gang⋅Zhao, Gang⋅Wan, Jun⋅Wan, Jun⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming and He, Xiaoming
Nature nanotechnology, vol. 15, (no. 4), pp. 342, 2020-Apr. | Journal Article
 
Bioinspired One Cell Culture Isolates Highly Tumorigenic and Metastatic Cancer Stem Cells Capable of Multilineage Differentiation
Wang, Hai⋅Wang, Hai⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Jiang, Bin⋅Jiang, Bin⋅Stewart, Samantha⋅Stewart, Samantha⋅Liu, Xuanyou⋅Liu, Xuanyou⋅Liang, Yutong⋅Liang, Yutong⋅Hancioglu, Baris⋅Hancioglu, Baris⋅Webb, Amy⋅Webb, Amy⋅Fisher, John P⋅Fisher, John P⋅Liu, Zhenguo⋅Liu, Zhenguo⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Tkaczuk, Katherine H. R⋅Tkaczuk, Katherine H R⋅He, Xiaoming and He, Xiaoming
Advanced Science, pp. 2000259, 2020-04-28. | Journal Article
 
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer.
Sun, Lei⋅Wan, Arabella⋅Zhou, Zhuolong⋅Chen, Dongshi⋅Liang, Heng⋅Liu, Chuwei⋅Yan, Shijia⋅Niu, Yi⋅Lin, Ziyou⋅Zhan, Siyue⋅Wang, Shanfeng⋅Bu, Xianzhang⋅He, Weiling⋅Lu, Xiongbin⋅Xu, Anlong and Wan, Guohui
Gut, November 20, 2020. | Journal Article
 
ST2 as checkpoint target for colorectal cancer immunotherapy
Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Jiang, Hua⋅Jiang, Hua⋅Jiang, Hua⋅Jiang, Hua⋅Yu, Tao⋅Yu, Tao⋅Yu, Tao⋅Yu, Tao⋅Yang, Jinfeng⋅Yang, Jinfeng⋅Yang, Jinfeng⋅Yang, Jinfeng⋅Kamocka, Malgorzata M⋅Kamocka, Malgorzata M⋅Kamocka, Malgorzata M⋅Kamocka, Malgorzata M⋅So, Ka Man⋅So, Ka Man⋅So, Ka Man⋅So, Ka Man⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Sandusky, George E⋅Sandusky, George E⋅Sandusky, George E⋅Sandusky, George E⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Braun, Harald⋅Braun, Harald⋅Braun, Harald⋅Braun, Harald⋅Beyaert, Rudi⋅Beyaert, Rudi⋅Beyaert, Rudi⋅Beyaert, Rudi⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Paczesny, Sophie⋅Paczesny, Sophie⋅Paczesny, Sophie⋅Paczesny, Sophie⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin and Lu, Xiongbin
JCI insight, vol. 5, (no. 9), 2020-May-07. | Journal Article
2019
Creating a capture zone in microfluidic flow greatly enhances the throughput and efficiency of cancer detection
Sun, Mingrui⋅Sun, Mingrui⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Shamul, James G⋅Shamul, James G⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Husain, Syed⋅Husain, Syed⋅He, Xiaoming and He, Xiaoming
Biomaterials, vol. 197, pp. 170, March 2019. | Journal Article
 
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet
Luo, Yongde⋅Luo, Yongde⋅Luo, Yongde⋅Luo, Yongde⋅Luo, Catherine K⋅Luo, Yongde⋅Luo, Catherine K⋅Yang, Yaying⋅Yang, Yaying⋅Yang, Yaying⋅Yang, Yaying⋅Yang, Vincent W⋅Yang, Vincent W⋅Yang, Yaying⋅Liu, Yan⋅Liu, Muyun⋅Liu, Yan⋅Liu, Muyun⋅Liu, Muyun⋅Liu, Muyun⋅Liu, Muyun⋅Wang, Dan⋅Wang, Guoqiang⋅Wang, Dan⋅Wang, Feng⋅Wang, Xiaojie⋅Wang, Dan⋅Wang, Guoqiang⋅Wang, Feng⋅Wang, Xiaojie⋅Wang, Dan⋅Wang, Dan⋅Wang, Feng⋅Wang, Feng⋅Wang, Feng⋅Bi, Yawei⋅Bi, Yawei⋅Bi, Yawei⋅Bi, Yawei⋅Bi, Yawei⋅Ji, Juntao⋅Ji, Juntao⋅Ji, Baoan⋅Ji, Juntao⋅Ji, Juntao⋅Ji, Juntao⋅Ji, Baoan⋅Li, Xiaokun⋅Li, Ellen⋅Li, Suyun⋅Li, Suyun⋅Li, Suyun⋅Li, Zhaoshen⋅Li, Zhaoshen⋅Li, Ellen⋅Li, Suyun⋅Li, Suyun⋅Li, Xiaokun⋅Liu, Yan⋅Liu, Yan⋅Liu, Yan⋅Chen, Rong⋅Chen, Rong⋅Chen, Rong⋅Chen, Rong⋅Chen, Rong⋅Huang, Haojie⋅Huang, Haojie⋅Huang, Haojie⋅Huang, Haojie⋅Huang, Haojie⋅Wang, Xiaojie⋅Wang, Xiaojie⋅Wang, Xiaojie⋅Swidnicka-Siergiejko, Agnieszka K⋅Swidnicka-Siergiejko, Agnieszka K⋅Swidnicka-Siergiejko, Agnieszka K⋅Swidnicka-Siergiejko, Agnieszka K⋅Swidnicka-Siergiejko, Agnieszka K⋅Janowitz, Tobias⋅Janowitz, Tobias⋅Janowitz, Tobias⋅Janowitz, Tobias⋅Janowitz, Tobias⋅Beyaz, Semir⋅Beyaz, Semir⋅Beyaz, Semir⋅Beyaz, Semir⋅Beyaz, Semir⋅Wang, Guoqiang⋅Wang, Guoqiang⋅Wang, Guoqiang⋅Xu, Sulan⋅Xu, Sulan⋅Xu, Sulan⋅Xu, Sulan⋅Xu, Sulan⋅Bialkowska, Agnieszka B⋅Bialkowska, Agnieszka B⋅Bialkowska, Agnieszka B⋅Bialkowska, Agnieszka B⋅Bialkowska, Agnieszka B⋅Luo, Catherine K⋅Luo, Catherine K⋅Luo, Catherine K⋅Pin, Christoph L⋅Pin, Christoph L⋅Pin, Christoph L⋅Pin, Christoph L⋅Pin, Christoph L⋅Liang, Guang⋅Liang, Guang⋅Liang, Guang⋅Liang, Guang⋅Liang, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Weiqin⋅Lu, Xiongbin⋅Lu, Weiqin⋅Wu, Maoxin⋅Wu, Maoxin⋅Wu, Maoxin⋅Wu, Maoxin⋅Wu, Maoxin⋅Shroyer, Kenneth R⋅Shroyer, Kenneth R⋅Shroyer, Kenneth R⋅Shroyer, Kenneth R⋅Shroyer, Kenneth R⋅Wolff, Robert A⋅Wolff, Robert A⋅Wolff, Robert A⋅Wolff, Robert A⋅Wolff, Robert A⋅Plunkett, William⋅Plunkett, William⋅Plunkett, William⋅Plunkett, William⋅Plunkett, William⋅Ji, Baoan⋅Ji, Baoan⋅Ji, Baoan⋅Li, Zhaoshen⋅Li, Zhaoshen⋅Li, Zhaoshen⋅Li, Ellen⋅Li, Ellen⋅Li, Ellen⋅Li, Xiaokun⋅Li, Xiaokun⋅Li, Xiaokun⋅Yang, Vincent W⋅Yang, Vincent W⋅Yang, Vincent W⋅Logsdon, Craig D⋅Logsdon, Craig D⋅Logsdon, Craig D⋅Logsdon, Craig D⋅Logsdon, Craig D⋅Abbruzzese, James L⋅Abbruzzese, James L⋅Abbruzzese, James L⋅Abbruzzese, James L⋅Abbruzzese, James L⋅Lu, Weiqin⋅Lu, Weiqin and Lu, Weiqin
Gastroenterology, vol. 157, (no. 5), pp. 1428.e11, November 2019. | Journal Article
 
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Chen, Yu-Hsiang⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Solzak, Jeffrey P⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Ahmad, Mufti N⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Wedge, David C⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Brinza, Dumitru⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Scafe, Charles⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Veitch, James⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Gottimukkala, Rajesh⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Short, Walt⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Atale, Rutuja V⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Ivan, Mircea⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Badve, Sunil S⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Miller, Kathy D⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan and Radovich, Milan
Breast cancer research : BCR, vol. 21, (no. 1), pp. 87, 2019-08-05. | Journal Article
 
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
Xu, Jiangsheng⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Wang, Hai⋅Wang, Hai⋅Wang, Hai⋅Stewart, Samantha⋅Stewart, Samantha⋅Stewart, Samantha⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Zhao, Gang⋅Zhao, Gang⋅Zhao, Gang⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming⋅He, Xiaoming and He, Xiaoming
Nature nanotechnology, vol. 14, (no. 5), pp. 496, 2019-Mar-05. | Journal Article
2018
Author Correction: Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
Yaglom, Julia A⋅Yaglom, Julia A.⋅Yaglom, Julia A.⋅Wang, Yongmei⋅Wang, Yongmei⋅Wang, Yongmei⋅Li, Amy⋅Li, Amy⋅Li, Amy⋅Li, Zhenghu⋅Li, Zhenghu⋅Li, Zhenghu⋅Monti, Stephano⋅Monti, Stephano⋅Monti, Stephano⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Sherman, Michael Y⋅Sherman, Michael Y. and Sherman, Michael Y.
Scientific reports, vol. 8, (no. 1), pp. 1, 2018-May-02. | Journal Article
 
Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
Yaglom, Julia A⋅Yaglom, Julia A⋅Yaglom, Julia A⋅Yaglom, Julia A.⋅Yaglom, Julia A.⋅Wang, Yongmei⋅Wang, Yongmei⋅Wang, Yongmei⋅Wang, Yongmei⋅Wang, Yongmei⋅Li, Amy⋅Li, Amy⋅Li, Amy⋅Li, Amy⋅Li, Amy⋅Li, Zhenghu⋅Li, Zhenghu⋅Li, Zhenghu⋅Li, Zhenghu⋅Li, Zhenghu⋅Monti, Stephano⋅Monti, Stephano⋅Monti, Stephano⋅Monti, Stephano⋅Monti, Stephano⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Alexandrov, Ilya⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Sherman, Michael Y⋅Sherman, Michael Y⋅Sherman, Michael Y⋅Sherman, Michael Y. and Sherman, Michael Y.
Scientific reports, vol. 8, (no. 1), pp. 12, 2018-02-14. | Journal Article
 
Enhanced cancer therapy with cold-controlled drug release and photothermal warming enabled by one nanoplatform
Wang, Hai⋅Wang, Hai⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Liang, Yutong⋅Liang, Yutong⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Zhao, Gang⋅Zhao, Gang⋅Tkaczuk, Katherine H R⋅Tkaczuk, Katherine H.R⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming and He, Xiaoming
Biomaterials, vol. 180, pp. 278, October 2018. | Journal Article
 
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhou, Zhuolong⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Luo, Zhenhua⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Deng, Yibin⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅Huang, Kun⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅He, Bin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅Wang, Jin⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin and Lu, Xiongbin
Nature communications, vol. 9, (no. 1), pp. 15, 2018-10-22. | Journal Article
 
N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development
Niu, Yi⋅Wan, Arabella⋅Lin, Ziyou⋅Lu, Xiongbin and Wan, Guohui
Acta Pharmaceutica Sinica B, vol. 8, (no. 6), pp. 843, 2018-10-00. | Journal Article
 
Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial
Wang, Hai⋅Wang, Hai⋅Agarwal, Pranay⋅Agarwal, Pranay⋅Zhao, Gang⋅Zhao, Gang⋅Ji, Guang⋅Ji, Guang⋅Jewell, Christopher M⋅Jewell, Christopher M⋅Fisher, John P⋅Fisher, John P⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming and He, Xiaoming
ACS Central Science, vol. 4, (no. 5), pp. 581, 20180523. | Journal Article
 
Regulation of protein metabolism in cancer
Han, Cecil⋅Lu, Xiongbin and Nagrath, Deepak
Molecular & Cellular Oncology, vol. 5, (no. 5), pp. e1285384, 9/3/2018. | Journal Article
 
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer
Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Van der Jeught, Kevin⋅VanderJeught, Kevin⋅Van der Jeught, Kevin⋅VanderJeught, Kevin⋅Van der Jeught, Kevin⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin and Lu, Xiongbin
The Journal of clinical investigation, vol. 128, (no. 7), pp. 2965, 2018-07-02. | Journal Article
 
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
Wang, Hai⋅Gao, Zan⋅Liu, Xuanyou⋅Agarwal, Pranay⋅Zhao, Shuting⋅Conroy, Daniel W⋅Ji, Guang⋅Yu, Jianhua⋅Jaroniec, Christopher P⋅Liu, Zhenguo⋅Lu, Xiongbin⋅Li, Xiaodong and He, Xiaoming
Nature communications, vol. 9, (no. 1), pp. 16, 2018-02-08. | Journal Article
 
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt
Katreddy, Rajasekhara Reddy⋅Bollu, Lakshmi Reddy⋅Su, Fei⋅Xian, Na⋅Srivastava, Shivangi⋅Thomas, Rintu⋅Dai, Yubing⋅Wu, Bing⋅Xu, Yunlu⋅Rea, Michael A⋅Briggs, James M⋅Zhang, Qingyuan⋅Lu, Xiongbin⋅Huang, Gangxiong and Weihua, Zhang
Oncogenesis, vol. 7, (no. 1), pp. 13, 2018-Jan-23. | Journal Article
 
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Liu, Yunhua⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Choi, Hyun Ho⋅Choi, Hyun Ho⋅Choi, Hyun Ho⋅Han, Cecil⋅Han, Cecil⋅Han, Cecil⋅Han, Cecil⋅Han, Cecil⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Fang, Yuanzhang⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Li, Yujing⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Van der Jeught, Kevin⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Xu, Hanchen⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Zhang, Lu⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Frieden, Michael⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Wang, Lifei⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Eyvani, Haniyeh⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Sun, Yifan⋅Zhao, Gang⋅Zhao, Gang⋅Zhao, Gang⋅Zhao, Gang⋅Zhao, Gang⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Zhang, Yuntian⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Liu, Sheng⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Wan, Jun⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Huang, Cheng⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Ji, Guang⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅He, Xiaoming⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna⋅Zhang, Xinna and Zhang, Xinna
Nature communications, vol. 9, (no. 1), pp. 16, 2018-11-09. | Journal Article
2017
Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery
Agarwal, Pranay⋅Agarwal, Pranay⋅Wang, Hai⋅Wang, Hai⋅Sun, Mingrui⋅Sun, Mingrui⋅Xu, Jiangsheng⋅Xu, Jiangsheng⋅Zhao, Shuting⋅Zhao, Shuting⋅Liu, Zhenguo⋅Liu, Zhenguo⋅Gooch, Keith J⋅Gooch, Keith J⋅Zhao, Yi⋅Zhao, Yi⋅Lu, Xiongbin⋅Lu, Xiongbin⋅He, Xiaoming and He, Xiaoming
ACS Nano, vol. 11, (no. 7), pp. 6702, 20170725. | Journal Article